Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-30

Clinical Trial Update: Evaluate the Infectivity Equivalence of Current and New Lots of Plasmodium Falciparum Strain NF54 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing infectivity equivalence between current and new lots of Plasmodium falciparum NF54 strain; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Malaria,Falciparum | Phase 1 | Status: COMPLETED | Results posted: 2021-03-30